| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |